A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease
Jeffrey L. Anderson, MD, FACCa,
Jessica Habashi, BSa,
John F. Carlquist, PhDa,
Joseph B. Muhlestein, MD, FACCa,
Benjamin D. Horne, MPHa,
Tami L. Bair, BSa,
Robert R. Pearson, BSa and
Noal Hart, BSa
a University of Utah, LDS Hospital, Salt Lake City, Utah, USA

View larger version (14K):
[in a new window]
|
Figure 1 Kaplan-Meier survival-time plot for cardiovascular death by AMPD1 genotype (wild type vs. variant heterozygote or homozygote). There are four events (4.4%) among 90 patients carrying the mutant polymorphism and 33 events (11.9%) among noncarriers, a statistically significant difference (log-rank statistic 4.0, p = 0.046; Breslow statistic 4.1, p = 0.043). Solid line = AMPD1() variant carrier; dotted line = variant noncarrier.
|
|
|